We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Informatics Software Application Challenges Researchers to "Ask for Knowledge from Data”

By LabMedica International staff writers
Posted on 16 Sep 2009
New data integration and knowledge software can be applied to visualizing and confirming data-driven hypotheses.

IO Informatics, Inc. More...
(Berkeley, CA, USA), a provider of semantically-enabled life science/healthcare data integration and knowledge software, revealed its new innovative knowledge application, Applied Semantic Knowledgebase (ASK), during a presentation at the recent GTCBio "Rediscovering Biomarkers” Conference, held in San Diego, CA, USA, in August 2009.

Bob Stanley, IO Informatics president and CEO, told the conference attendees, "ASK allows you to move beyond traditional data capture and integration to realize practical value from the knowledge contained in your data. It provides a collection of specific models, built directly from your research, which can be applied to visualizing and validating data-driven hypotheses, as well as for knowledge-based screening and decision-making. ASK gives you a decisive competitive advantage in many areas, such as biomarker-based predictive biology and personalized medicine, including, but not limited to, target profile creation and validation, compound efficacy and promiscuity screening, toxicity profiling and detection, disease signature detection, predictive clinical trials pre-screening, and patient stratification.”

Mr. Stanley went on to clarify how ASK is delivered via the Sentient software suite and is a combination of three of its core technologies: the Sentient software framework for data access and integration; state-of-the-art Semantic methods and applications; and innovative SPARQL array tools. The combination of these technologic capabilities provides researchers with the ability to capture, access, organize, and apply the knowledge contained in their data, in order to solve critical scientific and business challenges.

"Our goal as your partners in discovery,” Mr. Stanley explained, "is to apply our experience and expertise in both software and informatics methods relating to your specific research interests, so that you can obtain and apply the answers you need to solve your complex scientific and related business questions.”

Building on its advanced data access and integration capabilities, Sentient applies semantic patterns to create predictive network models using virtually any combination of internal experimental data and/or external published information. These patterns apply semantic SPARQL query technology to build complex searches across multiple information sets. SPARQL is a new type of semantic search technology capable of detecting patterns within and between different data types and relationships, even if the initial datasets are not formally joined under any common database schema or data federation method.

These patterns or models are then placed in an ASK which is unique to the scientists research focus. The researcher is then able to exploit the knowledge contained within the ASK, by querying the models themselves or by additionally creating new datasets for deeper investigation and analysis. "This transformational technology,” concluded Mr. Stanley, "makes it possible to actively leverage previously disconnected data--creating valuable knowledge that can be used to deliver a revolutionary set of applications for the life-science industry and personalized medicine.”

IOI develops software for data integration and knowledge applications. Its Semantically-enabled Sentient software suite allows life science, biotechnology, pharmaceutical, and medical researchers to structure and define complex data relationships across data sources, view these relationships, query them, and capitalize on them--all within a secure, compliant, auditable framework that helps organizations accumulate and utilize knowledge.

Related Links:

IO Informatics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.